Abbisko Therapeutics and AstraZeneca collaborate to conduct combination clinical trial for NSCLC

Co-Diagnostics advances toward FDA filing after completing clinical validation for respiratory point-of-care test

Nuvation Bio's taletrectinib Marketing Authorisation Application for advanced ROS1-positive non-small cell lung cancer treatment validated in UK

Grünenthal completes Nociceptin Receptor (NOP) Agonist Phase I trial

United Therapeutics wins FDA approval for LungFX ex vivo lung perfusion device

bioMérieux files FDA application for rapid vaginitis diagnostic panel

Racura Oncology doses first patient in Phase 1 lung cancer trial

EU approves Cenrifki for secondary progressive multiple sclerosis without relapses

Oxford BioTherapeutics reports progress in Boehringer Ingelheim partnered programmes

Genprex receives Canadian Patent Allowance for Reqorsa gene therapy combination in lung cancer

Transgene expands myvac platform into non-small cell lung cancer with TG4070

Kither Biotech completes Phase 1 KIT2014 clinical study

Simcere Pharmaceutical and Stanford Medicine agree research collaboration in idiopathic pulmonary fibrosis

Airiver Medical treats first chronic rhinosinusitis patient in Drug Coated Balloon clinical study

Precigen and the RRPF recognise International RRP Awareness Day